Invitation to Vimian’s Interim Report for the third quarter of 2023
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Läkemedel & Handel |
Vimian Group AB will publish its Interim Report for the third quarter of 2023 on Wednesday, 8 November 2023, at 07.45 (CET). An audiocast will be organised for investors, analysts and media, on the same day at 09.00 (CET).
CEO Fredrik Ullman and CFO Carl-Johan Zetterberg Boudrie, will present and comment on the report. In addition, Magnus Kjellberg, CEO of Vimian’s Specialty Pharma segment Nextmune, will provide a brief overview of Nextmune. The audiocast will be held in English and include a question-and-answer session.
To attend the telephone conference:
Dial-in number to the teleconference will be received by registering on the link below. After the registration you will be provided phone numbers and a conference ID to access the conference. You can ask questions verbally via the telephone conference.
https://conference.financialhearings.com/teleconference/?id=5004723
To attend the webcast:
Link: https://ir.financialhearings.com/vimian-group-q3-report-2023
Related presentation materials will be available on Vimian’s website (https://vimian.com/investors/reports-and-presentations/) ahead of the telephone and web conference.